Effects of Anti-TSLP on Airway Hyperresponsiveness and Mast Cell Phenotype in Asthma - A Randomized Double-blind, Placebo-controlled Trial of MEDI9929
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2017
At a glance
- Drugs Tezepelumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms UPSTREAM
- 07 Jun 2017 Biomarkers information updated
- 03 Jan 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 03 Jan 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.